The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $31.35

Today's change-0.16 -0.51%
Updated April 29 11:36 AM EDT. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $31.35

Today's change-0.16 -0.51%
Updated April 29 11:36 AM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

Medifast Inc is lower today, dropping (U.S.)$0.16 or 0.51% to (U.S.)$31.35 after setting a new 100-day high. Over the last five days, shares have gained 2.82% and 3.19% year to date. Shares have outperformed the S&P 500 by 4.41% during the last year.

Key company metrics

  • Open(U.S.) $31.31
  • Previous close(U.S.) $31.51
  • High(U.S.) $31.57
  • Low(U.S.) $31.03
  • Bid / Ask(U.S.) $31.27 / (U.S.) $31.35
  • YTD % change+3.19%
  • Volume15,175
  • Average volume (10-day)65,271
  • Average volume (1-month)73,604
  • Average volume (3-month)110,853
  • 52-week range(U.S.) $26.14 to (U.S.) $33.56
  • Beta0.75
  • Trailing P/E19.35×
  • P/E 1 year forward18.11×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.00
  • Dividend yield3.19%
  • Trailing EPS(U.S.) $1.62
Updated April 29 11:36 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.17%

Based on its net profit margin of 7.17%, Medifast Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue61667273
Total other revenue--------
Total revenue61667273
Gross profit45495354
Total cost of revenue16171920
Total operating expense56586367
Selling / general / administrative40414547
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income6897
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax6897
Income after tax4564
Income tax, total2332
Net income4664
Total adjustments to net income--------
Net income before extra. items4564
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4564
Inc. avail. to common incl. extra. items4664
Diluted net income4664
Dilution adjustment0------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.330.450.480.36
Dividends per sharevalue per share0.250.000.000.00
Diluted normalized EPSvalue per share0.330.450.480.36